InflaRx NV (InflaRx NV) Total Assets : $116.41 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV Total Assets?

InflaRx NV's Total Assets for the quarter that ended in Mar. 2024 was $116.41 Mil.

During the past 12 months, InflaRx NV's average Total Assets Growth Rate was 30.70% per year. During the past 3 years, the average Total Assets Growth Rate was 55.90% per year. During the past 5 years, the average Total Assets Growth Rate was 63.20% per year.

During the past 9 years, InflaRx NV's highest 3-Year average Total Assets Growth Rate was 152.00%. The lowest was 47.70%. And the median was 106.00%.

Total Assets is connected with ROA %. InflaRx NV's annualized ROA % for the quarter that ended in Mar. 2024 was -33.93%. Total Assets is also linked to Revenue through Asset Turnover. InflaRx NV's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

InflaRx NV Total Assets Historical Data

The historical data trend for InflaRx NV's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InflaRx NV Total Assets Chart

InflaRx NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

135.09

107.32

141.40

108.48

131.09

InflaRx NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															92.41	144.06	138.19	131.09	116.41

InflaRx NV Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

InflaRx NV's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	111.867	+	19.222
	=	131.09

InflaRx NV's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	103	+	13.409
	=	116.41

InflaRx NV (NAS:IFRX) Total Assets Explanation

Total Assets is connected with ROA %.

InflaRx NV's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-41.988	/	( (131.089	+	116.408)	/ 2 )
	=	-41.988	/	123.7485
	=	-33.93 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

InflaRx NV's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.039	/	( (131.089	+	116.408)	/ 2 )
=	0.039	/	123.7485
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

InflaRx NV Total Assets Related Terms

Thank you for viewing the detailed overview of InflaRx NV's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

InflaRx NV (InflaRx NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (NAS:IFRX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

IF0:Germany IF0:Germany

Address

Winzerlaer Strasse 2, Jena, DEU, 07745

Website

https://www.inflarx.de

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.